JPRN-UMIN000035738尚未招募2 期
A phase II study of HFNC in advanced cancer patients with dyspnea and poor PS - A phase II study of HFNC in advanced cancer patients with dyspnea and poor PS
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who need 8 or more opioid rescue use per day. 2. Patients who plan artificial respiration management. 3. Patients who already have used HFNC. 4. Patients who have disturbance of consciousness of 12 or less GCS. 5. Patients under sustained sedation. 6. Patients with cognitive impairment or mental disorder who are regarded as inadequate to evaluate for the study by the investigators. 7. Patients who have participated in the other study at the time of the informed consent, or will participate in the other study. 8. Any other cases who are regarded as inadequate for the study enrollment by the investigators.
研究者
相似试验
招募中
2 期
Multicenter Phase II Study of AHCC (Functional Food) to Explore Improvement in Treatment Outcome in Patients with Unresectable Pancreatic CancerPancreatc cancerPancreatic cancerJPRN-jRCTs051210156Satoi Sohei130
招募中
2 期
Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck CancerLocally Advanced Head and Neck CancerNCT03532737Kuwait Cancer Control Center50
已完成
1 期
Phase I Study of Intratumoral Administration of HF10, Oncolytic Herpes Simplex Virus Type 1, in Patients with Advanced Unresectable Pancreatic CancerAdvanced Unresectable Pancreatic CancerJPRN-UMIN000010150agoya University School of Medicine9
已完成
2 期
Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line TreatmentNCT04511455Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest22
Unknown
1 期
Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory GatingCarcinoma, Non-Small-Cell LungNCT00690963AHS Cancer Control Alberta12